Patients were divided into two groups, including low- (IRS ≤ 7) and high- (IRS ≥ 8) COL6A2 expression groups, and COL6A2 in glioma tissue microarray (TMA) was detected by IHC. This evidence concerns the gene COL6A2 and glioma.